Literature DB >> 16724368

Conventional systemic agents for psoriasis. A systematic review.

Bruce E Strober1, Kimberly Siu, Kavi Menon.   

Abstract

Very few well designed studies have evaluated the conventional systemic agents for psoriasis. This is a systematic, evidence-based review of the literature evaluating both the efficacy and safety of the medications cyclosporine, methotrexate, acitretin, hydroxyurea, and 6-thioguanine. Treatment recommendations are made.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16724368

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


  17 in total

Review 1.  Treatment algorithms for early psoriatic arthritis: do they depend on disease phenotype?

Authors:  William Tillett; Neil McHugh
Journal:  Curr Rheumatol Rep       Date:  2012-08       Impact factor: 4.592

2.  Xiaoyin recipe ( ) for psoriasis induces a Th1/Th2 balance drift toward Th2 in peripheral blood mononuclear cells of experimental autoimmune thyroiditis rats.

Authors:  Xiao-Guang Xu; Hong Zhang; Xin-Ling Bi; Jun Gu; Yu-Ling Shi; Qiang Hou
Journal:  Chin J Integr Med       Date:  2012-02-05       Impact factor: 1.978

Review 3.  Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.

Authors:  D E Furst; F C Breedveld; J R Kalden; J S Smolen; G R Burmester; J Sieper; P Emery; E C Keystone; M H Schiff; P Mease; P L C M van Riel; R Fleischmann; M H Weisman; M E Weinblatt
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 19.103

4.  [Treatment recommendations for psoriatic arthritis].

Authors:  W-H Boehncke
Journal:  Z Rheumatol       Date:  2009-12       Impact factor: 1.372

Review 5.  Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Authors:  Emilie Sbidian; Anna Chaimani; Ignacio Garcia-Doval; Giao Do; Camille Hua; Canelle Mazaud; Catherine Droitcourt; Carolyn Hughes; John R Ingram; Luigi Naldi; Olivier Chosidow; Laurence Le Cleach
Journal:  Cochrane Database Syst Rev       Date:  2017-12-22

6.  [Psoriatric arthritis - a permanent challenge for rheumatologists and patients: part 2: imaging diagnostics, classification and therapy].

Authors:  S Finzel; M Englbrecht
Journal:  Z Rheumatol       Date:  2011-11       Impact factor: 1.372

7.  IL-10 implications in psoriasis.

Authors:  Ahmad A Al-Robaee; Abdullateef A Al-Zolibani; Hani A Al-Shobili; Amira Kazamel; Ahmad Settin
Journal:  Int J Health Sci (Qassim)       Date:  2008-01

8.  The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis.

Authors:  Jaroslav Chládek; Marie Simková; Jaroslava Vanecková; Milos Hroch; Jirina Chládkova; Jirina Martínková; Jaroslava Vávrová; Martin Beránek
Journal:  Eur J Clin Pharmacol       Date:  2007-12-29       Impact factor: 2.953

Review 9.  Psoriatic arthritis: pharmacotherapy update.

Authors:  Philip J Mease
Journal:  Curr Rheumatol Rep       Date:  2010-08       Impact factor: 4.592

Review 10.  Treatment recommendations for psoriatic arthritis.

Authors:  C T Ritchlin; A Kavanaugh; D D Gladman; P J Mease; P Helliwell; W-H Boehncke; K de Vlam; D Fiorentino; O Fitzgerald; A B Gottlieb; N J McHugh; P Nash; A A Qureshi; E R Soriano; W J Taylor
Journal:  Ann Rheum Dis       Date:  2008-10-24       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.